Delivery Order SPE2DB22D2007-SPE2DB23FJ3YN
Award Date 7/10/23
Potential Completion Date 7/11/23
Potential Value $503
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $543.52 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will take place in Conshohocken, Pennsylvania over one day in early July 2023. No subcontractors or set aside designations were indicated. This order is likely placed against DLA's pharmaceutical prime...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $452.70 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period beginning August 1, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on August 29, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $502,860 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a testosterone replacement drug. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in July 2023. The delivery order was issued under the DLA's Pharmaceutical Prime Vendor contract vehicle, which provides pharmaceuticals and...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $334.47 firm fixed price delivery order by the Defense Logistics Agency to supply 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy medication, for performance at its Conshohocken, Pennsylvania facility from July 21-24, 2023. The award is issued against the DLA's pharmaceutical prime vendor contract vehicle to support the medical readiness of DOD personnel. No subcontractors...
- Amerisourcebergen Drug Corp has been awarded a $1,002.12 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical contract vehicle to supply 50 MG/0.5 ML auto-injectors of XYOSTED, a medication for testosterone replacement therapy. Performance will occur in Conshohocken, Pennsylvania by October 2023. The Defense Logistics Agency supports military readiness by procuring and providing medical supplies and pharmaceuticals to the Department of Defense. No...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $754.26 firm fixed price delivery order by the Defense Logistics Agency to supply 50mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy, for performance in Conshohocken, Pennsylvania from August 4-7, 2023. As the prime contractor for delivery order under an unspecified agency-wide contract vehicle, Amerisourcebergen will fulfill the Defense Logistics Agency's requirement for this...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at $754.26 by the Defense Logistics Agency to supply XYOSTED 75 MG/0.5 ML auto-injectors. The firm fixed price order is for performance from July 17-18, 2023 at the contractor's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues such requirements to support medical readiness for the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $4,539.12 to Amerisourcebergen Drug Corporation for the supply of 75 mg/0.5 ml auto-injectors of XYOSTED. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period spanning August 21-22, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set aside designations were indicated. This order is...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy, for delivery to a location in Conshohocken, Pennsylvania from August 11-14, 2023. The contract was awarded utilizing the Defense Logistics Agency's Pharmaceutical Prime Vendor program, which provides pharmaceuticals and other medical supplies to...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ3YNDelivery Order
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $502.86 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will take place in Conshohocken, Pennsylvania under a one-day period from July 10-11, 2023. No subcontractors or set aside designations were indicated. This order is likely placed against DLA's pharmaceutical prime vendor contract to support the medical readiness of DOD personnel.
Generated 12/18/23, 6:44 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $503 | 7/10/23 |